Savara Company Description

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis.

The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Savara Inc.

Country	United States
Founded	2007
Industry	Pharmaceutical Preparations
Employees	59
CEO	Matthew Pauls

Contact Details

Address: 1717 Langhorne Newtown Road Langhorne, Delaware 19047 United States
Phone	512 614 1848
Website	savarapharma.com

Stock Details

Ticker Symbol	YB4P
Exchange	Frankfurt Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Matthew Pauls	Chief Executive Officer
David Lowrance	Chief Financial Officer
Robert Lutz	Chief Operating Officer